Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,994.00
Bid: 1,983.00
Ask: 1,985.00
Change: -16.00 (-0.80%)
Spread: 2.00 (0.101%)
Open: 2,010.00
High: 2,014.00
Low: 1,978.00
Prev. Close: 2,010.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: UK stocks advance as investors shrug off weak data

Thu, 21st Aug 2014 12:01

- Mining stocks fall as Chinese data weakens- Eurozone PMIs and UK retail sales disappoint- US data, Jackson Hole aheadtechMARK 2,810.76 +0.50%FTSE 100 6,772.04 +0.25%FTSE 250 15,797.15 +0.31%Falls in the heavyweight mining sector weren't enough to stop the FTSE 100 from advancing on Thursday despite a barrage of weak economic data from across the globe."The data seen so far today hasn't been great but that hasn't affected investors' appetite for risk, as European indices have continued their march higher," said market analyst Craig Erlam from Alpari UK.London's Footsie was trading 0.25% higher at 6,772 by midday.Economic data misses forecastsMining stocks were under pressure in morning trade after manufacturing data from top metals consumer China disappointed, while metals prices weakened on the back of a stronger US dollar.The HSBC China manufacturing purchasing managers' index (PMI) dropped from 51.7 to a three-month low 50.3 in August. The fall ended a streak of four straight monthly improvements in activity growth and disappointed analysts looking for a slight dip to 51.5.The Eurozone composite PMI, which measures activity in both manufacturing and services, fell from 53.8 to 52.8 in August, missing the 53.4 forecast as readings from both sectors came in below expectations.Closer to home, UK retail sales growth came in at just 0.1% in July, under the 0.4% increase expected by analysts, according to Office for National Statistics. The ONS also released figures showing that while UK public finances improved last month borrowing still remains above the government's target.Looking ahead to the US session, stock futures on Wall Street were edging higher in pre-market trade ahead of a host of economic data, including jobless claims, the Markit manufacturing PMI, existing-home sales and the Philadelphia Fed index.Meanwhile, the Jackson Hole Symposium of central bankers is due to kick off later on with comments from policymakers around the world likely to be closely watched.Mining stocks fallWeak data from top metals consumer China and falling metal prices dampened the demand for mining stocks on Wednesday with Fresnillo, Randgold, Rio Tinto, Anglo American and BHP Billiton trading lower.BHP Billiton was still under pressure in the aftermath of Tuesday's underwhelming plans for a demerger. Chief financial officer Graham Kerr, who is due to be the head of the spin-off company, has been cited as saying that the lack of a share buyback - which many investors had been expecting - was a "sore point", while plans to give shareholders stock in the new firm could have "irritated" some who are not mandated to hold investments in Australia. Kazakh metal miner Kazakhmys hailed progress with a shake-up designed to focus it on the lucrative copper market, but shares fell sharply after it said 2014 gold production was likely to fall short of hopes.Oil and gas stocks were also out of favour including Ophir Energy, Tullow and Shell.Premier Oil was more or less flat after saying it had a "strong six months" with better-than-expected production leading to higher revenues and cash flows. However, it saw a sharp reduction in pre-tax profit in the first half due to impairments.Leading the upside in London were a raft of pharmaceutical and biotechnology stocks, including Astrazeneca, Glaxosmithkline, Shire and Hikma Pharmaceuticals.Financials such as Schroders, Aviva, Old Mutual and Hargreaves Lansdown were also providing a lift.FTSE 100 - RisersSchroders (SDR) 2,385.00p +2.36%AstraZeneca (AZN) 4,372.50p +2.04%GlaxoSmithKline (GSK) 1,438.00p +1.45%CRH (CRH) 1,391.00p +1.31%Ashtead Group (AHT) 945.50p +1.23%Old Mutual (OML) 196.20p +1.13%Barratt Developments (BDEV) 363.50p +1.08%Aviva (AV.) 521.00p +1.07%Diageo (DGE) 1,769.00p +1.00%Hargreaves Lansdown (HL.) 1,120.00p +0.99%FTSE 100 - FallersFresnillo (FRES) 938.50p -3.50%Kingfisher (KGF) 306.60p -1.73%Anglo American (AAL) 1,576.50p -1.10%Randgold Resources Ltd. (RRS) 4,947.00p -1.00%Royal Mail (RMG) 441.80p -0.88%Antofagasta (ANTO) 812.00p -0.85%Rio Tinto (RIO) 3,430.00p -0.81%Standard Chartered (STAN) 1,211.50p -0.78%Pearson (PSON) 1,120.00p -0.71%easyJet (EZJ) 1,330.00p -0.67%FTSE 250 - RisersRank Group (RNK) 166.00p +3.49%Imagination Technologies Group (IMG) 204.90p +3.48%Hikma Pharmaceuticals (HIK) 1,740.00p +2.84%Domino Printing Sciences (DNO) 647.00p +2.70%International Personal Finance (IPF) 519.00p +2.57%Amlin (AML) 439.00p +2.26%Fisher (James) & Sons (FSJ) 1,366.00p +2.25%Euromoney Institutional Investor (ERM) 1,073.00p +2.19%Senior (SNR) 287.70p +2.17%Xaar (XAR) 558.50p +2.10%FTSE 250 - FallersKazakhmys (KAZ) 292.90p -5.06%Thomas Cook Group (TCG) 119.80p -3.39%Just Retirement Group (JRG) 145.30p -3.20%Hochschild Mining (HOC) 162.20p -2.29%Centamin (DI) (CEY) 62.85p -2.26%Petra Diamonds Ltd.(DI) (PDL) 186.80p -2.05%Ophir Energy (OPHR) 225.20p -1.96%African Barrick Gold (ABG) 240.30p -1.52%Serco Group (SRP) 305.10p -1.39%Stock Spirits Group (STCK) 290.50p -1.36%BC
More News
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.